Results 121 to 130 of about 17,683 (178)

Massive Submacular Hemorrhage Following Intravitreal Faricimab Injection for Neovascular Age-Related Macular Degeneration. [PDF]

Cureus
Kaganovski A, Rostomian N, Shrier E.
europepmc   +1 more source

Real-world treatment outcomes of aflibercept versus bevacizumab for neovascular age-related macular degeneration. [PDF]

Graefes Arch Clin Exp Ophthalmol
Mhmud H, Vermeulen JP, Adanc B, Klevering JBJ, Groenink-Lindenhovius C, Tigchelaar OAM, Ponsioen TL, Klaver CCW, Witmer AN.   +8 more
europepmc   +1 more source

Efficacy of brolucizumab and ranibizumab in diabetic macular edema and neovascular age-related macular degeneration: insights from a case series. [PDF]

Ann Med Surg (Lond)
Hossain B, Rahmatullah S, Ahmed T.
europepmc   +1 more source

Therapeutic Equivalence of Eyluxvi (Aflibercept) to Eylea in Neovascular Age-Related Macular Degeneration: ALTERA Trial (Randomized). [PDF]

Ophthalmol Ther
Raczynska D, Ernest J, Baumane K, Sagong M, Akiyama K, Rauschning W, Vajas A, Nowosielska A, Dusova J, Majtánová N, Oleksy P, Kuneva I, Resch M, Lange N, Briede E, Bajdik B, Jeong A, Kozub B, Papp A.   +18 more
europepmc   +1 more source

Short term real-world effectiveness of faricimab in neovascular age-related macular degeneration patients in the Republic of Korea. [PDF]

Sci Rep
Chung DH, Jee D, Roh YJ, Ra H, Lee MY, Won JY, Shin JA, Jung SH, Park YH.   +8 more
europepmc   +1 more source

Integrating genetics, age and imaging to predict treatment outcomes in neovascular age-related macular degeneration: a proof-of-concept study. [PDF]

Sci Rep
Moghul I, Pontikos N, Sharma A, Liu T, Soomro T, Wagner SK, Silva AS, Zhang G, Naik G, Bagga P, Chan YW, Keane PA, Cipriani V, Sivaprasad S, Webster AR, Balaskas K.   +15 more
europepmc   +1 more source

Efficacy of Faricimab in Neovascular Age-Related Macular Degeneration: A Single-Arm Systematic Review and Meta-Analysis.

Ophthalmic Res
Karam M, Baeshen M, Alfuzaie R, Mohammad M, Alshatti A, Samet A, Paez-Escamilla M, Sun V.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Neovascular Age-Related Macular Degeneration

Ophthalmologica, 2012
<i>Purpose:</i> Neovascular age-related macular degeneration (AMD) is a leading cause of blindness, with an increasing incidence as the elderly population expands. Large, multi-center, randomized, clinical trials have been conducted exploring the safety and efficacy of anti-VEGF treatments. This paper aims to discuss the safety and efficacy
VERITTI, Daniele, SARAO, Valentina, LANZETTA, Paolo   +2 more
openaire   +3 more sources

Neovascular Age-Related Macular Degeneration

2015
Age-related macular degeneration (AMD) is the leading cause of severe vision loss in individuals over the age of 50 years. Choroidal neovascularization (CNV) is the hallmark of 'wet' or 'exudative' AMD, and is responsible for approximately 90% of cases of severe vision loss due to AMD. Vascular endothelial growth factor (VEGF) is a key component in the
Jack, Shao, Maria M, Choudhary, Andrew P, Schachat   +2 more
openaire   +3 more sources